Airing Pain 114: You, Your Drugs, and the Law: Gabapentinoids and medicinal cannabis
How does the law affect people who use drugs to manage their pain?
This edition is funded by Foundation Scotland
On 1 April 2019 Pregabalin and Gabapentin, drugs recommended for the management of neuropathic pain, were re-classified as class C controlled substances.
Medicinal Cannabis: Is it safe? Does it work for pain? Is it legal?
Where do people who use these drugs to manage their chronic pain now stand within UK law?
Issues covered in this programme include: Cannabinoids, cannabis, epilepsy, seizures, drugs, medication, policy, gabapentin, classification, legality, prescription, neuropathic pain, pregabalin, Schedule One drugs and Schedule Two drugs.
- Blair Smith, Consultant in Pain Medicine at NHS Tayside, and National Lead Clinician for Chronic Pain in Scotland
- Steve Alexander, Associate Professor in Molecular Pharmacology at Nottingham University
- Cameron Rashide who lives with neuropathic pain.
Registered Charity no. SC023559. Company limited by guarantee no. SC546994. 62-66 Newcraighall Road, Edinburgh EH15 3HS